Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.53 USD | +2.65% | +4.62% | -33.36% |
Apr. 09 | Synaptogenix, Inc. acquired Unknown Stake in Psyga Bio Ltd from Cannasoul Analytics Ltd. | CI |
Apr. 03 | Synaptogenix Plans 1-for-25 Reverse Stock Split; Shares Fall | MT |
Business Summary
Number of employees: 5
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alan Tuchman
CEO | Chief Executive Officer | 77 | 17-12-31 |
Daniel Alkon
PSD | President | 81 | 20-12-06 |
Robert Weinstein
DFI | Director of Finance/CFO | 64 | 13-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Tuchman
CEO | Chief Executive Officer | 77 | 17-12-31 |
Bruce Bernstein
BRD | Director/Board Member | 60 | 16-11-13 |
Joshua Silverman
CHM | Chairman | 53 | 16-08-03 |
Director/Board Member | 50 | 18-12-12 | |
William Singer
BRD | Director/Board Member | 82 | 13-08-22 |
Daniel Alkon
PSD | President | 81 | 20-12-06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,085,333 | 1,058,910 ( 97.57 %) | 0 | 97.57 % |
Stock B | 0 | 6,000 | 0 | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-33.36% | 4.92M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- SNPX Stock
- Company Synaptogenix, Inc.